Company Filing History:
2 out of 480 
1 out of 4 Years Active: 2016-2020
Title: Juliana Chung-Ngor Chan: Pioneering Biomarker Research for Diabetes and Cardiovascular Diseases
Introduction
Juliana Chung-Ngor Chan, based in Tai Po, China, is a prominent inventor focusing on the field of biomarkers related to major health conditions such as diabetes and cardiovascular diseases. With two patents to her name, her innovative work has the potential to change the way these chronic conditions are assessed and treated.
Latest Patents
Chan's latest patents highlight her commitment to advancing medical science. The first patent, titled "Biomarkers for Diabetes," provides a method for assessing the risk of developing type 2 diabetes and related diseases. This involves detecting sequence variations in critical genes like carboxypeptidase E (CPE) and insulin degradation enzyme (IDE). The invention includes a kit, array, and device that enable this assessment, along with a method for treating patients who have been identified with specific genetic variants.
Her second patent, "DACH1 as a Biomarker for Diabetes," extends her research into the Dachshund homolog 1 (DACH1) gene. This invention also provides a method for assessing the risk of developing type 2 diabetes and cardiovascular disease by detecting sequence variations in the DACH1 gene. It encompasses a kit and device designed for this assessment, as well as treatment methods for patients with relevant genetic variations.
Career Highlights
Chan has had a distinguished career, contributing her expertise to respected institutions such as The Chinese University of Hong Kong and The Hospital Authority. Her work in these organizations has been instrumental in the progression of medical research focused on genetic profiling and disease prevention.
Collaborations
Throughout her career, Chan has collaborated with notable colleagues, including Wing-Yee So and Ronald Ching-Wan Ma. These collaborations have fostered a thriving environment for innovation and have enhanced the research outcomes in the field of biomedical sciences.
Conclusion
Juliana Chung-Ngor Chan’s inventions have the potential to revolutionize the approaches we take toward diagnosing and treating diabetes and cardiovascular diseases. Her work exemplifies the significant impact that innovative thinking and research can have on health outcomes, making her a remarkable figure in the world of biomedical invention.